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ABSTRACT Progesterone is a neuroprotective, promyelinating and antiinflammatory 
factor for the nervous system. Here we discuss progesterone effects in models of 
motoneuron degeneration and neuroinflammation. In neurodegeneration of the 
Wobbler mouse, a subset of spinal cord motoneurons showed increased activity of 
nitric oxide synthase (NOS), increased intramitochondrial NOS, decreased activity of 
respiratory chain complexes and decreased activity and protein expression of Mn-
superoxide dismutase type 2 (MnSOD2). Clinically, Wobblers suffered several 
degrees of motor impairment. Progesterone treatment restored the expression of 
neuronal markers, decreased the activity of NOS and enhanced complex I 
respiratory activity and MnSOD2. Long-term treatment with progesterone increased 
muscle strength, biceps weight and survival. Collectively, these data supported that 
progesterone prevented neurodegeneration. To study progesterone effects in 
neuroinflammation, we employed mice with experimental autoimmune 
encephalomyelitis (EAE). EAE mice spinal cord showed increased mRNA levels of  
the inflammatory mediators tumour necrosis factor α (TNFα) and its receptor TNFR1, 
the microglial marker CD11b, iNOS and the toll-like receptor 4 (TLR4). Progesterone 
pretreatment of EAE mice blocked the proinflammatory mediators, decreased Iba1+ 
microglial cells and attenuated clinical signs of EAE. Therefore, reactive glial cells 
became targets of progesterone anti-inflammatory effects. These results open the 
ground for testing the usefulness of neuroactive steroids for neurological disorders.  
 
Key words: progesterone; neuroprotection; Wobbler mouse; anti-inflammatory 
effects; experimental autoimmune encephalomyelitis.  
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Progesterone´s protective role in motoneuron degeneration 
Experimental and clinical evidence indicate a protective role of progesterone 
in disorders of the central and peripheral nervous system including traumatic brain 
and spinal cord injury, neuroinflammation, stroke,  ischemia, diabetic neurophathy, 
neurophatic pain  and neurodegeneration [ 1 – 8 ]. A human neurodegenerative 
disease targeting motoneurons of the spinal cord, brain stem and motor cortex is 
amyotrophic lateral sclerosis (ALS) [9]. ALS patients show a fatal outcome in less 
than 5 years, which can be retarded for a few months by treatment with the anti-
glutamatergic drug riluzole [10].  Therefore, alternative procedures to ameliorate the 
course of this disease are urgently needed. 
 
There are several animal models of ALS, among them the Wobbler mouse [11, 
12]. Wobblers suffer a mutation in the gene coding for VPS54 (vacuolar vesicular 
protein sorting) present in chromosome 11. In common with patients with the 
sporadic form of ALS, Wobblers motoneurons show a relocation of TDP-43 (nuclear 
transactive DNA-binding protein) from the nuclear to the cytoplasmic compartment 
and changes of ubiquitin [13]. This finding make Wobblers potential models for 
sporadic ALS, a form of the disease accounting for about 85-90 % of all cases [11].  
Morphologically, anterior horn motoneurons of Wobbler mice undergo a dramatic 
perikaryal vacuolar degeneration, accompanied by astrocytosis and microglial 
activation [11, 12, 14,15]. This type of neuronal death is known as cytoplasmic type II 
cell death or paraptosis [16]. Participation of oxidative stress in this mechanism is 
supported by the clinical, biochemical and morphological improvement caused by 
treatment with antioxidants, antiglutamatergic drugs, steroids, nitric oxide inhibitors 
and neurotrophic factors [ 17 - 19]. In addition to vacuolation, we demonstrated in 
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Wobbler mice motoneurons abnormal expression of several molecules such as nitric 
oxide synthase (NOS), Na,K-ATPase, brain-derived neurotrophic factor (BNDF), 
choline-acetyltransferase (ChAT) and growth-associated protein GAP-43, in addition 
to deficits of retrograde axonal transport [ 19 - 21].  
 
 Progesterone protective effects were first studied in symptomatic Wobbler 
mice showing full-blown expression of the disease, i.e., ambulatory difficulties, 
muscle atrophy and forelimb flexion. These mice remained untreated or received a 
single progesterone pellet (20 mg) under the skin of the neck. After 18 days of 
treatment, vacuolated motoneurons in the spinal cord of progesterone-treated 
Wobblers were already reduced 6-fold, with a concomitant reduction of NOS active 
neurons. Deactivation of nitric oxide producing mechanisms could relieve 
motoneurons from increased oxidative stress [22]. Although the mechanisms of 
progesterone action were not studied in Wobbler motoneurons, the presence of 
substantial amounts of the reduced derivatives 5α-dihydroprogesterone (DHP) and 
3α,5α-tetrahydroprogesterone (THP) in plasma and spinal (Guennoun et al., 
unpublished results) cord suggest that progesterone effects could be mediated by 
different receptors. In this regard, classical intracellular receptors, membrane 
receptors (α, β, and γ subtypes), the PMC1 (formerly 25Dx) as well as GABA A 
receptors, that bind progesterone and/ or its reduced metabolites have been 
demonstrated in the spinal cord [ 1, 23 - 26 ].  
 
 In addition to decrease vacuolation of motoneurons, exposure of 
Wobbler mice to progesterone prevented other neuronal abnormalities. These 
included the expression of neuronal BDNF mRNA and the subcellular distribution of 
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BDNF protein. Expression levels of neuronal BDNF mRNA, measured by in situ 
hybridization, were lower in Wobbler mice compared to control mice. The neurotrophin 
was up-regulated by progesterone in α-motoneurons which innervate the forelimbs 
muscles, smaller neurons such as γ-motoneurons that control muscle spindle organs, 
Renshaw inhibitory cells and interneurons of Wobblers [ 27 ]. These responses 
pointed to an intrinsically complex regulation of BDNF expression in the neuronal 
network of the ventral horn. Prima facie, up-regulation of endogenous BDNF should 
be helpful to Wobbler mice, because treatment of these animals with exogenous 
BDNF slows motoneuron degeneration, diminishes axon loss and enhances 
behavioral parameters related to locomotor activity [ 28 ]. In a time-course study, we 
observed that BDNF mRNA, which was already depleted at the presymptomatic stage 
of the Wobbler disease, continued to be poorly expressed at the symptomatic and late 
stages. Progesterone treatment replenished BDNF mRNA progesterone preferentially 
in the last two stages, when motoneuron degeneration was more severe [29]. 
However, BDNF protein content analyzed by ELISA in ventral horns or by 
immunostaining of motoneurons, remained normal in steroid-naïve Wobblers at the 
established stage but was decreased by progesterone, suggesting that the steroid 
increased anterograde transport and /or release of neuronal BDNF. Working in an 
autocrine manner, BDNF bins to neuronal tropomiosine-kinase type B receptors 
(TrkB) and activate gene transcription employing different signaling cascades [30]. 
Preliminary data showed that TrkB mRNA was reduced in untreated Wobblers and 
increased following progesterone treatment. Concomitantly, steroid treatment down-
regulated the expression of p75ntr, a pan neurotrophin receptor type mediating death 
signals after binding neurotrophins (Gonzalez Deniselle et al. unpublished results). 
Thus, progesterone could play a dual role, in part by stimulation of endogenous BDNF 
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and TrkB, and in part by decreasing neurotrophin binding to p75 ntr. . BDNF released 
from motoneurons after progesterone stimulation could bind to the TrkB receptors in 
nearby neurons in a paracrine manner [30]. A paracrine role for BDNF has been 
proposed following axotomy, degenerative diseases and ischemia [ 32 - 34]. Besides 
neurons, other potential targets of neuronal-secreted BDNF are the oligodendrocytes, 
in which the neurotrophin increases myelin synthesis [ 34 ]. We also showed that 
progesterone-stimulated BDNF in the Wobbler mouse was concomitant to changes of 
the oligodendrocytes. Wobbler mice showed a depletion of CC1 immunopositive 
oligodendrocytes in the white matter of the spinal cord, whereas progesterone 
treatment enhanced the density of BDNF/CC1 double labeled oligodendrocytes at all 
stage periods of the disease [29].  Thus, BDNF-mediated progesterone effects could 
protect neurons from degeneration and also promote myelination acting on the 
oligodendrocytes.  
 
Progesterone treatment of Wobbler mice also resulted in changes in ChAT, 
the enzyme responsible for acetylcholine synthesis. Untreated Wobbler mice 
presented a significant reduction in ChAT-immunoreactive motoneurons, indicating 
they are dysfunctional neurons that lost the ChAT phenotype before dying [ 27 ]. A 
time-course study revealed that ChaT was reduced at all stages of the Wobbler 
disease [ 31 ]. In agreement with the results in Wobblers, ChAT-immunoreactivity is 
also diminished in the spinal cord of ALS patients [ 34 ]. We found that in the 
forelimb muscles of Wobbler mice, ChAT activity was reduced by 55.3% compared 
to control animals, which also agreed with similar findings in other laboratories [ 36 ]. 
Depletion of ChAT-IR in neurons and enzyme activity in nerve terminals are not 
permanent but plastic events, because progesterone induced a significant increment 
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in ChAT-positive neuronal density in the spinal cord and increased enzyme activity in 
the muscle. In this way, cholinergic neurotransmission and muscle contraction could 
be recovered after progesterone treatment of the Wobbler mouse.  
 
 During the course of the Wobbler disease, of critical importance is the 
production of neurotoxic levels of NO by neurons and astrocytes [20, 37]. Excess 
levels of NO bind to and alter the function of the mitochondrial respiratory chain [22].  
Work from other laboratories have already demonstrated that mitochondria from the 
spinal cord and motor cortex of Wobbler mice present respiratory chain dysfunction 
with decreased oxygen consumption, decreased complex I and complex IV activities, 
decreased state 3 and 4 respiration rates, decreased oxidative phosphorylation and 
aberrant activation of delta PKC that modulates mitochondrial-induced apoptosis [ 38, 
39].  Ultrastructurally, motoneurons from Wobbler mice show mitochondrial 
membrane disruption, cristolysis and vacuolation [ 19 ]. The abnormal mitochondria 
are a source of free radicals, superoxide anion and nitric oxide due to the high 
activity of a mitochondrial nitric oxide synthase (mtNOS) [40].  Considering the 
significant role played by mitochondria in cell metabolism and function, prevention of 
mitochondriopathy could result in healthier and functional motoneurons.   
 
The possibility that neurotoxic levels of NO caused vacuolation of 
motoneurons, prompted the analysis of nNOS content. Data gathered by Western 
blot showed an increased signal for nNOS in mitochondria (mtNOS) from the cervical, 
but not lumbar spinal cord, of steroid-naïve Wobblers compared to control and 
progesterone-receiving Wobblers. In contrast, cytosolic nNOS in the same groups 
seemed unchanged in the cervical portion and weakly present in the lumbar region, 
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as illustrated in Fig. 1. Measurement of the NADPH-diaphorase activity of NOS by 
histochemistry demonstrated several staining profiles in the untreated Wobbler, 
which may correspond to nitrergic motoneurons. In contrast, NADPH-diaphorase 
active motoneurons were greatly decreased in progesterone-treated Wobblers 
(Fig.1). As a further step, the expression for nNOS mRNA was determined in ventral 
horn motoneurons from Lamina IX of the cervical region of the spinal cord by in situ 
hybridization. However, no significant differences in grain density were obtained 
between control, Wobbler and Wobbler plus progesterone groups. Similarly, when 
the nNOS mRNA content was measured in the cervical spinal cord by real time PCR, 
differences were not found between control mice, untreated Wobblers and Wobbler 
plus progesterone groups. Altogether, these results suggest that gene transcription 
was not involved on the effects of the Wobbler mutation and progesterone treatment 
on mitochondrial mtNOS [41]. 
 
 Having demonstrated the presence of increased intramitochondrial  nNOS in 
the cervical spinal cord of Wobbler mice, and its reversal by progesterone treatment, 
we studied the consequences that changes of nNOS could have on respiratory chain 
components. Determination of mitochondrial complex I activity showed a significant 
reduction in the cervical and lumbar regions of the spinal cord of untreated Wobbler 
mice. Progesterone treatment returned complex I activity to normal in the cervical 
region, .but not in the lumbar region. Complex II-III activity of Wobbler mitochondria 
from the cervical region showed significantly reduced activity, but progesterone was 
unable to recover it.  Measurement of complex IV activity (cytochrome oxidase) did 
not produce significant differences between control, Wobbler and Wobbler plus 
progesterone groups in the cervical or lumbar spinal cord. In conclusion, 
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progesterone recovered mitochondrial respiratory complex I activity in the cervical 
spinal cord, the region preferentially affected by the Wobbler neuropathology [41]. .  
 
The mechanism(s) responsible for the increased level of mtNOS in the 
Wobbler, and the opposing effect of progesterone effect on this parameter seems an 
important point deserving elucidation. One possibility could be a decreased axonal 
transport of nNOS to the axonal terminal.  Accumulation of the enzyme in the 
cytoplasm may facilitate its entry into the mitochondria. Although the mechanisms of 
nNOS translocation are poorly defined, post-translational modifications of the 
enzyme such as phosphorylation or acylation have been proposed to control the 
import of this enzyme into the mitochondria [40]. A role of progesterone in these 
mechanisms remains to be established, although modulation of nNOS transport into 
mitochondria seems appealing. Since mtNOS and NO may cause motoneuron 
vacuolation and mitochondriopathy in the Wobbler, a closer look at the interaction 
between NO and progesterone may bring into light future therapeutic possibilities for 
neurodegeneration 
 
 Oxidative stress is normally opposed by different cellular protective 
mechanisms, such as the superoxide dismutases (SOD). Within the mitochondria, 
MnSOD constitutes a leading defence against superoxide anion damage. This raises 
the question on whether anti-oxidant mechanisms failing in the Wobbler could be 
restored by progesterone. To elucidate this issue, we studied the effects of the 
Wobbler mutation and progesterone treatment on MnSOD activity and 
immunostaining, and found that enzyme activity was reduced by half in the Wobbler 
mice compared to control and Wobbler mice receiving progesterone. We also found 
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that the number of MnSOD immunopositive motoneurons was slightly, albeit 
significantly reduced, in the Wobblers vs. controls, and in this case, progesterone 
treatment of Wobbler mice normalized the number of MnSOD stained motoneurons 
[41]. It was interesting to find out that degenerating motoneurons retain their 
capability to increase mitochondrial MnSOD in response to a protective stimulus, 
preventing the cellular damage provoked by reactive oxygen species originated in 
Wobbler motoneurons.  
 
Changes of neurochemical parameters under the influence of progesterone 
were accompanied by marked clinical improvements. Thus, long-term progesterone 
treatment attenuated the ongoing atrophy of forelimb biceps bracchii, increased 
muscle strength and prolonged survival of Wobbler mice [19]. Progesterone 
protective effects in the Wobbler mouse encouraged studies in patients with 
neurodegenerative diseases. In this regard, steps were taken to look for a possible 
role of progesterone in humans with ALS.   
 
Based on the progesterone protective effects in the Wobbler mouse, we 
assume that if variations occurred in serum progesterone levels in patients with ALS, 
they may influence the degree of damage to the central nervous system. In line with 
this hypothesis, we have searched if an association existed between progesterone 
levels with prognostic factors and survival of patients with ALS  [42]. We observed in 
a population of ALS patients, that endogenous progesterone serum concentrations 
were positively correlated with better prognostic factors, like survival and length of 
time from disease onset to diagnosis, and negatively correlated with age, a worse 
prognostic factor. Likewise, bulbar onset patients showed lower progesterone levels 
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in comparison to spinal onset patients, a condition of better disease prognosis. The 
origin of serum progesterone could be the adrenal gland, because gonadal 
progesterone decreases with aging. Pattachioli et al [ 43] have shown increased 
activity of the HPA axis in ALS patients, suggesting hyperadrenocorticism.  However, 
it has still to be ascertained whether progesterone elevation in ALS responds to a 
pathological activation of the HPA axis or if it is a mechanism to confront 
neurodegeneration. We have considered that progesterone levels in ALS patients 
may possible influence ALS prognosis and survival.  To this end, it would be crucial 
to find out if progesterone levels in the cerebrospinal fluid and in post-mortem tissues 
are also changed in ALS patient, to better elucidate the contribution of 
neuroprogesterone.  In a second study employing ALS patients and age-matched 
healthy controls, we analyzed the relationship between circulating steroid levels and 
respiratory function, taking into account that ALS patients end up with assisted 
ventilation due to respiratory failure. We found that an elevated progesterone/cortisol 
ratio in blood levels was associated with better forced vital capacity, a measure of 
good respiratory function [44 ].   
 
In a third study performed with post-mortem tissues, the spinal cord of control 
subjects and ALS patients was processed for determination of progesterone receptors 
(PR) mRNA by PCR and for PR localization using immunostaining.  PR was localized in 
motoneurons, blood vessels and glial cells of both normal and degenerating human 
spinal cords. PR mRNA was determined in the cervical and lumbar regions of the spinal 
cord. Results have shown that in the cervical region, mRNA for PR (A+B isoforms) and 
PR B isoform were similar in controls and ALS. In the lumbar region, ALS patients 
showed a significantly higher expression of PR B than control subjects. These data 
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indicated that (a) PR was expressed in the human spinal cord, and (b) the possibility 
existed for a higher expression of PR in ALS patients. Combined with progesterone 
levels found in ALS patients, PR data implies that up-regulation of protective factors 
constitute a reparative effort to attenuate neurodegeneration (Gargiulo-Monachelli et al. 
unpublished data).  Altogether, data obtained in humans suggests the possibility that 
progesterone treatment may be clinically useful in a chronic neurodegenerative disorder 
like ALS.  
 
Progesterone effects in a neuroinflammation model 
Multiple sclerosis (MS) is an inflammatory disease targeting the central 
nervous system. MS is considered of autoimmune origin, driven by myelin specific 
CD4+ T helper-1 (Th1) cells and inflammatory cytokines [45, 46]. There is also 
strong evidence for neurodegeneration in MS [ 47 ]. Intrinsic defects of the 
oligodendrocytes, with release of myelin proteins and debris that provoke a 
secondary reaction of the immune system have also been implicated [48]..  
 
 In approximately 80% of the cases MS shows a relapsing-remitting course, 
with a significant decline in the rate of relapses during the third trimester of 
pregnancy, and a significant return post partum. The absence of MS relapses during 
pregnancy is believed to be due to the protective and anti-inflammatory effects of sex 
steroid hormones circulating in high levels in pregnant women, whereas post-partum 
relapses may be due to decreased levels of circulating steroids [49]. Along the 
steroid hypothesis, a recent report has shown decreased levels of brain 
neurosteroids in patients with MS and mice with experimental autoimmune 
encephalomyelitis (EAE), the most common model of MS [50]. Therefore, the 
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potential therapeutic benefit of sex steroid hormones for MS patients has been taken 
into consideration [51]. 
Commonly, EAE is induced in rodents by immunization with one of the central 
myelin proteins. Neuropathology of EAE spinal cord includes inflammatory cell 
infiltration, demyelination with oligodendrocyte loss, microglial activation, axonal loss, 
astrocytosis and neuronal dysfunction [ 52 , 53]. Clinical correlates of spinal cord 
pathology include loss of tail tonicity, rear limb paralysis and even death [ 53 ]. 
Among other treatments, steroids have been successfully employed to prevent the 
development or halt the progression of EAE [ 53 - 59]. Therefore, EAE provides a 
useful model to analyze the effects of progesterone on neuroinflammation. 
 
Thus, based on current demonstrations that the spinal cord is sensitive to the 
protective effects of progesterone, as exemplified above for the neurodegeneration 
of the Wobbler mouse, we studied whether progesterone influences the inflammatory 
reaction of the spinal cord of EAE mice. To this purpose, female C57BL/6 mice were 
immunized with a myelin oligodendrocyte glycoprotein peptide (MOG40–54). One 
week before EAE induction, mice received single pellets of progesterone weighing 
100 mg or remained free of steroid treatment. On average, mice developed clinical 
signs of EAE 12 - 13 days following MOG administration. The spinal cord white 
matter of EAE mice showed circumscribed demyelinating areas, demonstrated by 
reductions of luxol fast blue (LFB) staining, myelin basic protein (MBP) and 
proteolipid protein (PLP) immunoreactivity (IR) and PLP mRNA expression [58,59]. 
In motoneurons, mice with EAE showed reduced expression of neuronal markers 
and axonal loss. These abnormalities were accompanied by a strong reaction of the 
cells composing the innate immune system, determined 17 days after immunization. 
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Thus, strong microglia reactivity, assessed by the microglial markers Iba1 and 
CD11b occurred in EAE mice. There was also a strong expression of several 
proinflammatory molecules, including tumor necrosis factor alpha (TNFα) and its 
receptor type 1, the toll-like receptor 4 (TLR4) and the inducible form of nitric oxide 
synthase (iNOS), as illustrated in Fig. 2. Notably, there was a 27-fold increase in 
TNFα mRNA increase in EAE mice [58]. Using double immunfluorescence staining 
and confocal microscopy, we localized TNFα with markers of microglia (OX42) and 
astrocytes (GFAP), which confirmed the participation of these cell types in the 
immune reaction. These inflammatory factors are deeply involved in spinal cord 
pathology [60]. TLR4 is highly expressed on microglia and other immune cells after 
trauma and inflammation of the central nervous system [61]. Stimulation of this 
receptor can lead to activation of NFkB and mitogen-activated protein (MAP) kinases 
and production of inflammatory mediators including TNFα, IL-6, IL1-b, intercellular 
adhesion molecule-1 (ICAM-1), and monocyte chemoattractant protein-1 (MCP-1) 
[62, 63]. In addition, deregulation of TLR4 could be partially responsible for EAE 
pathogenesis. Studies in vivo and in vitro have revealed that LPS exposure causes 
TLR4-dependent microglia activation associated with oligodendrocyte death, 
demyelination, neuronal and axonal loss, i.e., events that typically characterize EAE 
[63]. TNFα is a target gene downstream of TLR4 activation, explaining its higher 
expression in the spinal cord of EAE mice. In this regard, high levels of TNFα were 
identified in acute and chronic MS lesions suggesting its involvement in lesion 
formation [63]. In EAE, inhibition of TNFα with an IgG1 monoclonal antibody 
effectively prevented the disease [64]. 
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 In our experiments, we found that pretreatment of EAE mice with 
progesterone diminished microglial cell reactivity, leading to lower immunoreaction 
for Iba1 and mRNA for the CD11b microglial marker. As shown in Fig. 2, 
progesterone pretreatment decreased the expression of the mRNAs of the receptor 
TLR4, of the proinflammatory cytokine TNFα and its receptor TNFR1 and induced a 
slight reduction of iNOS mRNA in the spinal cord. Instead, other inflammatory 
molecules up-regulated by EAE were steroid-insensitive. The anti-inflammatory 
effects of progesterone may be ascribed to direct effects on reactive astrocytes and 
microglia [58,59]. In addition, progesterone significantly enhanced the expression of 
transcription factors involved in specification of the oligodendrocyte lineage and 
myelin repair, increased mature oligodendrocyte density and elevated the expression 
of mRNAs of the myelin protein MBP and PLP. Clinically, animals receiving hormone 
treatment\ showed an attenuation of neurological disability, as EAE mice without 
treatment reached grades 2 – 3 (i.e., monoplegia or paraplegia) whereas those 
receiving progesterone remained on the average on grade 1 (i.e., loss of tail tonicity) 
[59]. 
 
The immunomodulatory effects of progesterone have been recognized in 
other situations. Progesterone favors the development of T helper cells producing 
Th2-type cytokines [65]. Pregnant women with MS show a decrease in the relapse 
rate during the third trimester ascribed to high levels of estrogens and progesterone [ 
49, 51 ]. A significant attenuation of the microglial reactivity is observed in 
progesterone-treated EAE-treated mice probably by a direct steroid action upon 
these cells. Although the presence of progesterone receptors in microglia is 
controversial, direct antiinflammatory effects of progesterone and its derivatives on a 
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microglial cell line have been demonstrated [66]. Thus, impairment of microgliosis 
may be beneficial to EAE mice because these cells represent an important source of 
damaging inflammatory mediators. Thus, the decreased expression of TLR4 by 
progesterone may prevent the activation of proinflammatory genes, demyelination 
and oligodendrocyte death in EAE. This effect is in accordance with previous in vitro 
studies showing that pretreatment with pregnant levels of progesterone inhibited the 
up-regulation of TLR4 expression on murine macrophages exposed to LPS [67]. In 
traumatic brain injury, up-regulation of TLR4 mRNA is markedly inhibited by 
progesterone administration [68]. Progesterone attenuation of the high expression of 
TNFα mRNA in the spinal cord of EAE mice may lead to protection of myelinating 
cells. Oligodendrocytes and their progenitors are particularly vulnerable to the effects 
of this cytokine in vivo and in vitro. Indeed, treatment with TNFα-promotes apoptosis 
of mature oligodendrocytes and inhibits maturation and differentiation of their 
progenitors (OPC) [69, 70]. Colocalization studies showed that this cytokine was 
mainly produced by microglia and astrocytes. TNFα interaction with the TNFR1 could 
be responsible for the cytolytic activity of TNFα [71]. In this way, progesterone anti-
inflammatory actions were probably mediated in part by reduction of microgliosis and 
the mentioned proinflammatory mediators. iNOS expression was also attenuated by 
progesterone, which confirms results in other systems. Thus, in a spinal cord 
neurodegeneration model, progesterone decreases nitric oxide production, possibly 
acting on the nNOS isoform  [41]. Further studies are necessary to establish the role 
of iNOS and the other NOS isoforms in progesterone effects in a neuroinflammatory 
milieu. 
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In addition to the inflammatory mediators reported in the present study, other 
cytokines have been already demonstrated to be under the control of progesterone. 
These include a decrease of the inflammatory interleukins IL-2 and IL-17 and an 
increase of the anti-inflammatory IL-10 in EAE mice, decreases of IL-1β and TNFα in 
brain-injured rats and decreases of IL-1β, transforming growth factor (TGF)b2 
mRNAs after brain ischemia [ 72, 73 ]. Thus, suppression of the immune response 
seems a generalized property of progesterone in different experimental conditions. 
 
Therefore, exogenously administered progesterone constituted a novel 
therapeutic strategy during the acute phase of EAE [14].  However, endogenously 
produced steroids (neurosteroids) may also play a significant role during the course 
of EAE. Work of the Melcangi group  [ 74 ] has shown that in rats with induced EAE, 
there are dimorphic changes in the levels of progesterone and derivatives in different 
central nervous regions, as assessed by a highly specific gas chromatography/ mass 
spectrometry procedure. The authors have concluded that these studies may help to 
design therapies and possibly sex-specific therapies for MS.   
 
So far, we have observed that progesterone treatment in vivo produced anti-
inflammatory effects in EAE mice. In order to elucidate if these effects are entirely 
due to suppression of the peripheral immune system or to additional local spinal cord 
effects, we have resorted to a model of primary injury induced by the intraspinal 
injection of lysophospatidylcholine (LPC) [ 75 ]. In this study, C57Bl6 adult male mice 
remained steroid-naive or received a single 100 mg progesterone implant, which 
increased circulating steroid levels to those of mouse pregnancy. Seven days 
afterwards mice receivde a single injection of 1% LPC into the dorsal funiculus of the 
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spinal cord. This procedure induced local inflammation and demyelination. We 
observed that progesterone pretreatment of LPC-injected mice increased 
myelination, stimulated the proliferation of oligodendrocyte precursors and mature 
oligodendrocytes, and most importantly, attenuated the microglial/macrophage 
response. Thus, the LPC model supports direct progesterone anti-inflammatory 
effects in the spinal cord. 
 
 It is an accepted fact that progesterone-induced immunosuppression during 
human pregnancy may prevent relapses of MS. Based on this observation, the 
European Multicentric trial POPART-MUS is currently enrolling post-partum women with 
MS who receive a mixture of estrogen /progestin to simulate steroid levels achieved 
during pregnancy, in an attempt to avoid the incidence of post-partum relapses. This 
clinical trial is supported by demonstrations that estrogens and progesterone protected 
and /or attenuate EAE development [ 53 - 59 ]. The outcome of the POPART-MUS trial 
is eagerly waited because it may encourage the use of sex steroid hormones as 
protective factors for human MS.  
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Fig.1 : Western blot analysis of nNOS protein in mitochondria and cytosol fraction 
from control mice, Wobbler mice and Wobbler mice receiving progesterone. (a) 
Increased signal for nNOS in the cervical, but not the lumbar region of the spinal 
cord, from Wobbler mice (Wr) compared to control mice (CTL). Progesterone 
reduced nNOS signal intensity in Wobbler cervical cord (Wr PROG). (b) : Unchanged 
cytosolic nNOS signal in the cervical and lumbar regions of Wobbler compared to 
control or progesterone-treated Wobbler. (c) : Densitometric measurement 
(expressed in arbitrary units, AU) showed significantly higher nNOS protein content 
in Wobbler mitochondria from the cervical cord (* p<0.05) compared to control or 
progesterone-treated Wobbler. (d): Densitometric analysis of cytosolic nNOS 
showed similar levels in the cervical or lumbar regions in the three groups studied. 
(e): Stronger NADPH-diaphorase staining shown by Wobbler spinal cord (middle 
image) compared to control mouse or progesterone-treated Wobbler (upper and 
lower images, respectively). Arrowhead in the middle image points to a motoneuron, 
asterisk to probable endothelial cells. Microphotographs were taken from the cervical 
region of the spinal cord. Inside bar: 100 μm.  Data derived from Gonzalez Deniselle 
et al. [ 41 ].  
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Fig. 2: Quantitative analysis of the effects of progesterone on proinflammatory 
mediators in the spinal cord determined by real time PCR. The graphs represent 
CD11b (A), TLR4 (B), iNOS (C), TNFα (D) and TNFR1 (E) mRNAs. Statistical 
comparison showed that EAE up-regulated the microglial marker CD11b, 
proinflammatory molecules and iNOS mRNAs compared to control mice (CTRL): * 
p<0.05 for TNFα, CD11b, and TLR4, ** p<0.01 for TNFR1 and marginally increased 
iNOS. Progesterone treatment significantly decreased transcription of TNFα, TNFR1, 
CD11b and TLR4 mRNAs (all *p<0.05 vs EAE) and marginally decreased iNOS 
mRNA. Data derived from Garay et al. [ 58] .  
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